AU2923389A - A pharmaceutical composition - Google Patents

A pharmaceutical composition

Info

Publication number
AU2923389A
AU2923389A AU29233/89A AU2923389A AU2923389A AU 2923389 A AU2923389 A AU 2923389A AU 29233/89 A AU29233/89 A AU 29233/89A AU 2923389 A AU2923389 A AU 2923389A AU 2923389 A AU2923389 A AU 2923389A
Authority
AU
Australia
Prior art keywords
preparations
particles
pharmaceutical
pharmaceutical composition
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29233/89A
Other languages
English (en)
Inventor
Per Nilsson
Christer Nystrom
Marie Westerberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Publication of AU2923389A publication Critical patent/AU2923389A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
AU29233/89A 1988-01-13 1989-01-12 A pharmaceutical composition Abandoned AU2923389A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8800080A SE8800080L (sv) 1988-01-13 1988-01-13 Laekemedelskomposition
SE8800080 1988-01-13

Publications (1)

Publication Number Publication Date
AU2923389A true AU2923389A (en) 1989-08-11

Family

ID=20371045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29233/89A Abandoned AU2923389A (en) 1988-01-13 1989-01-12 A pharmaceutical composition

Country Status (6)

Country Link
EP (2) EP0324725B1 ( )
AT (1) ATE87467T1 ( )
AU (1) AU2923389A ( )
DE (1) DE68905613T2 ( )
SE (1) SE8800080L ( )
WO (1) WO1989006533A1 ( )

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685635B1 (fr) * 1991-12-27 1995-06-30 Lvmh Rech Particules solides complexes comprenant une substance solide biologiquement active, leur mode de preparation et compositions a usage topique les renfermant destinees au traitement de surfaces biologiques.
US5876758A (en) * 1989-08-04 1999-03-02 Lvmh Recherche Solid complex particles comprising a biologically active solid substance, mode of preparation and compositions for topical use containing them and intended to treat biological surfaces
US5385142A (en) * 1992-04-17 1995-01-31 Infrasonics, Inc. Apnea-responsive ventilator system and method
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
RU2345791C2 (ru) * 2003-01-31 2009-02-10 Орексо Аб Быстродействующая фармацевтическая композиция
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
RU2007133503A (ru) * 2005-02-10 2009-03-20 Орексо Аб (Se) Новые фармацевтические композиции, пригодные для трансмукозального введения лекарств
JP2008534563A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット パーキンソン病の治療に有用な新しい製薬組成物
JP2008534562A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット 偏頭痛の治療に有用な新しい製薬組成物
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
TW200824693A (en) 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
PT2706986E (pt) 2011-09-19 2015-07-07 Orexo Ab Nova composição farmacêutica resistente ao abuso para o tratamento da dependência de opiáceos

Also Published As

Publication number Publication date
DE68905613D1 (de) 1993-05-06
WO1989006533A1 (en) 1989-07-27
DE68905613T2 (de) 1993-10-07
EP0324725A1 (en) 1989-07-19
SE8800080L (sv) 1989-07-14
SE8800080D0 (sv) 1988-01-13
ATE87467T1 (de) 1993-04-15
EP0396599A1 (en) 1990-11-14
EP0324725B1 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
HU900708D0 (en) Process for preparation of substituted 1,3-oxathiolanes and pharmaceutical preparations containing them
AU1252088A (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
AU1819088A (en) New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
AU2923389A (en) A pharmaceutical composition
AU5221890A (en) 4(3h)-pteridinones, preparation processes and drugs containing them
AU590346B2 (en) Process for the preparation of halogenated (2,2)- paracyclophanes and mixtures of resultant halogenated (2,2)-paracyclophanes
AU629602B2 (en) Derivatives of benzocycloalkenyldihydroxyalkanoic, processes of preparation and medications containing them
HUT49370A (en) Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient
AU3488089A (en) Process for the preparation of catalyst particles and catalyst particles thus prepared
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
AU2687188A (en) New derivatives of cyclic amino acids, a process for the preparation thereof, agents containing them, and the use thereof
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ230356A (en) 2',3'-dideoxy-5-ethynyl-3'-fluorouridine: preparatory processes and pharmaceutical compositions
AU4480889A (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
HUT49320A (en) Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
IL117078A (en) Substituted benzenesulfonylureas and-thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
AU4369589A (en) Controlled-release delivery device, method for producing device, and method of using device
HRP960076B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds, as well as medicaments containing them
HUT52522A (en) Process for producing imidazol-substituted peptide derivatives and pharmaceutical compositions containing them as active components
HUT53591A (en) Process for producing polyhydroxy-benzayloxy-propanolamines and pharmaceutical compositions containing them as active component
HUT49364A (en) Process for producing sialosylglyceride derivatives and pharmaceutical compositions comprising such active ingredient
HRP960081B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them